/**/ RNS Number : 2696M Imaging Biometrics Limited 14 July 2026   Imaging Biometrics Limited (“IBAI” or the “Company”)   Sub-division   Further to the announcements of 12 May and 3 June, the Company is pleased to confirm that the sub-division has completed with a resulting 246,709,789 ordinary shares of £0.005. The Company has received…

Read more . . .

/**/ RNS Number : 4746H Imaging Biometrics Limited 09 June 2026   Imaging Biometrics Limited (“Company”) 9 June 2026   Publication of Phase 1 Clinical Trial of Oral Gallium Maltolate (GaM) in Recurrent Glioblastoma and Reopening of Expanded Access Programme Imaging Biometrics Limited (LSE: IBAI) announces the publication in the peer-reviewed journal Neuro-Oncology Advances describing…

Read more . . .

/**/ RNS Number : 0999H Imaging Biometrics Limited 05 June 2026   IMAGING BIOMETRICS LIMITED (“IBAI” or the “Company”) (LSE: IBAI) 5 June 2026     IB Neuro™ Commercialisation Plan – ASCO 2026 Phase II Results and Strategic Revenue Pathway   Imaging Biometrics Limited (LSE: IBAI) is pleased to update shareholders on the EAF151 Phase…

Read more . . .

/**/ RNS Number : 8611G Imaging Biometrics Limited 03 June 2026   03 June 2026    Imaging Biometrics Limited (“IBAI” or the “Company”)   Result of AGM   Imaging Biometrics Limited announces that at the annual general meeting of the Company held earlier today, all resolutions were duly passed.   For information, the proxy votes…

Read more . . .

/**/ RNS Number : 5405G Imaging Biometrics Limited 03 June 2026   IMAGING BIOMETRICS LIMITED (“IBAI” or the “Company”) (LSE: IBAI) AGM Statement and Business Update 3 June 2026 Imaging Biometrics Limited (LSE: IBAI) is pleased to provide this update to shareholders ahead of its Annual General Meeting being held today. The Group develops quantitative…

Read more . . .